Recent Insider Transactions - Apellis Pharmaceuticals (NASDAQ: APLS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

01/17/2025

Sell

$29.96

2,201

$66K

105,555

NASDAQ APLS Apellis Pharmaceuticals

Townsend Adam J. / officer: Chief Commercial Officer

01/17/2025

Sell

$29.96

2,201

$66K

88,068

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

01/17/2025

Sell

$29.96

1,730

$52K

86,370

NASDAQ APLS Apellis Pharmaceuticals

Nicholson Nur / officer: Chief Technical Officer

01/17/2025

Sell

$29.96

2,145

$64K

52,011

NASDAQ APLS Apellis Pharmaceuticals

Lewis Karen / officer: Chief People Officer

01/17/2025

Sell

$29.96

1,241

$37K

43,858

NASDAQ APLS Apellis Pharmaceuticals

Francois Cedric / director, officer: Chief Executive Officer

01/17/2025

Sell

$29.96

6,007

$180K

301,408

NASDAQ APLS Apellis Pharmaceuticals

Deschatelets Pascal / officer: Chief Scientific Officer

01/17/2025

Sell

$29.96

750

$22K

1.14M

NASDAQ APLS Apellis Pharmaceuticals

DeLong Mark Jeffrey / officer: Chief Business & Strat Officer

01/17/2025

Sell

$29.96

1,235

$37K

57,561

NASDAQ APLS Apellis Pharmaceuticals

Chopas James George / officer: VP/Chief Accounting Officer

01/17/2025

Sell

$29.96

715

$21K

36,643

NASDAQ APLS Apellis Pharmaceuticals

Baumal Caroline / officer: Chief Medical Officer

01/17/2025

Sell

$29.96

1,853

$56K

53,707

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

01/13/2025

Sell

$28.70

4,965

$143K

107,756

NASDAQ APLS Apellis Pharmaceuticals

Townsend Adam J. / officer: Chief Commercial Officer

01/13/2025

Sell

$28.70

2,685

$77K

90,269

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

01/13/2025

Sell

$28.70

2,170

$62K

88,100

NASDAQ APLS Apellis Pharmaceuticals

Nicholson Nur / officer: Chief Technical Officer

01/13/2025

Sell

$28.70

2,632

$76K

54,156

NASDAQ APLS Apellis Pharmaceuticals

Lewis Karen / officer: Chief People Officer

01/13/2025

Sell

$28.70

1,599

$46K

45,099

NASDAQ APLS Apellis Pharmaceuticals

Francois Cedric / director, officer: Chief Executive Officer

01/13/2025

Sell

$28.70

6,247

$179K

307,415

NASDAQ APLS Apellis Pharmaceuticals

Eisele Jeffrey / officer: Chief Development Officer

01/13/2025

Sell

$28.70

264

$8K

56,881

NASDAQ APLS Apellis Pharmaceuticals

Deschatelets Pascal / officer: Chief Scientific Officer

01/13/2025

Sell

$28.70

2,288

$66K

1.14M

NASDAQ APLS Apellis Pharmaceuticals

DeLong Mark Jeffrey / officer: Chief Business & Strat Officer

01/13/2025

Sell

$28.70

1,599

$46K

58,796

NASDAQ APLS Apellis Pharmaceuticals

Chopas James George / officer: VP/Chief Accounting Officer

01/13/2025

Sell

$28.70

783

$22K

37,358

NASDAQ APLS Apellis Pharmaceuticals

Walbert Keli / director

01/08/2025

Buy

$33.00

15,388

$508K

15,388

NASDAQ APLS Apellis Pharmaceuticals

Baumal Caroline / officer: Chief Medical Officer

01/06/2025

Sell

$33.81

2,816

$95K

55,560

NASDAQ APLS Apellis Pharmaceuticals

O'Brien Stephanie Monaghan / director

01/01/2025

Buy

$31.91

11,199

$357K

11,199

NASDAQ APLS Apellis Pharmaceuticals

Machiels Alec / director

01/01/2025

Buy

$31.91

11,199

$357K

11,199

NASDAQ APLS Apellis Pharmaceuticals

FONTEYNE PAUL R. / director

01/01/2025

Buy

$31.91

11,199

$357K

11,199

NASDAQ APLS Apellis Pharmaceuticals

Dunlop A. Sinclair / director

01/01/2025

Buy

$31.91

11,199

$357K

11,199

NASDAQ APLS Apellis Pharmaceuticals

Chan Gerald / director

01/01/2025

Buy

$31.91

11,199

$357K

11,199

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

12/31/2024

Buy

$13.85

10,054

$139K

90,270

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

12/31/2024

Sell

$13.85

10,054

$139K

84,946

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

12/31/2024

Buy

$14.95

1,042

$16K

80,216

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

12/31/2024

Sell

$14.95

1,042

$16K

23,958

NASDAQ APLS Apellis Pharmaceuticals

Eisele Jeffrey / officer: Chief Development Officer

12/23/2024

Sell

$33.09

$2K

57,145

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

12/11/2024

Sell

$34.24

5,000

$171K

112,721